Latest 10-K annual reports

Global Innovative Platforms Inc. reports significant R&D progress in breath analysis for animal disease detection, despite ongoing losses and a going concern warning.

Welsis Corp. reported a significant increase in net loss to $60,690 for fiscal year 2025, transitioning from teletherapy to a cryptocurrency exchange business while facing substantial doubt about its ability to continue as a going concern.

Mobix Labs reports continued operating losses and substantial doubt about its going concern ability, despite revenue growth driven by strategic acquisitions.

Anixa Biosciences, Inc. reported positive final Phase 1 clinical trial data for its investigational breast cancer vaccine and continued progress in its CAR-T ovarian cancer therapy, despite ongoing net losses and reliance on future funding.

Medicale Corp. reports no operations, a widening working capital deficit, and a going concern warning in its 2025 annual filing.

Hurco Companies, Inc. reported a net loss of $15.1 million for fiscal year 2025 on decreased sales of $178.6 million, while also securing a new $20.0 million secured revolving credit facility.

Maitong Sunshine Cultural Development Co., Limited reported increased revenue and reduced net loss for fiscal year 2025, but faces significant liquidity challenges and internal control weaknesses.

AnTix Holdings, formerly Innovative MedTech, Inc., reported a net income of $1.27 million for fiscal year 2025, driven by the sale of its SarahCare subsidiaries and a strategic pivot to AI-driven ticketing services.

North European Oil Royalty Trust reports a significant 49.5% increase in gross royalty income and higher distributions for fiscal year 2025, driven by elevated gas prices and favorable exchange rates despite declining gas sales volumes.

Standex International Corporation filed an amendment to its annual report to include the SEC-mandated Compensation Clawback Policy, previously omitted.

Kun Peng International Ltd. reported a significant net loss and negative working capital for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.

VisionWave Holdings, a technology company focused on AI and autonomous solutions for defense, completed its SPAC business combination, secured significant financing, and advanced product development in fiscal year 2025, despite reporting a substantial net loss.

Cleartronic, Inc. announced a 31.26% increase in revenue and a significant reduction in net loss for the fiscal year ended September 30, 2025, driven by strong ReadyOp platform subscriptions.

Regen Biopharma, Inc. filed its annual 10-K, revealing a significant increase in net loss to $1.27 million and substantial doubt about its ability to continue as a going concern, despite reduced operating cash burn.

Global Technologies, Ltd. reported a net loss of $342,681 for fiscal year 2025, driven by a strategic pivot to health technology and a restatement of prior year financials.

Daily Journal Corporation announced a significant increase in net income and EPS for fiscal year 2025, driven by strong performance in its Journal Technologies segment and substantial unrealized gains from its marketable securities portfolio.

Cemtrex, Inc. reported a substantial net loss of $28.3 million for fiscal year 2025, alongside significant capital raises and ongoing Nasdaq listing challenges, despite revenue growth in its Security and Industrial Services segments.

Fuse Group Holding Inc. reported a significant revenue drop and increased net losses for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.

Good Times Restaurants Inc. reported a slight revenue decrease and negative same-store sales for fiscal 2025, alongside a significant drop in net income, despite an increase in Bad Daddys' operating income.

IB Acquisition Corp. secured a business combination deadline extension to March 2026, but faced substantial share redemptions, significantly reducing its trust account balance.

Bodhi Tree Biotechnology Inc., an early-stage plant-based consulting firm, reported a significant increase in net loss and a decrease in revenue for the fiscal year ended September 30, 2025, alongside challenges in internal controls and market liquidity.

Standex International Corporation filed an amendment to its annual report to formally include its SEC-mandated Compensation Clawback Policy, adopted in August 2023.

CEL-SCI Corporation's latest 10-K filing highlights positive Phase III Multikine data for head and neck cancer, outlining plans for a confirmatory study while facing ongoing financial losses and a going concern doubt.

Graphjet Technology has been delisted from Nasdaq to OTC Pink Limited due to multiple non-compliance issues, while auditors express substantial doubt about its ability to continue as a going concern.

Broadway Financial Corporation has restated its 2024 and 2023 financial statements due to accounting errors related to loan participation agreements, reporting a significant drop in net income and diluted EPS for 2024.

VoIP-Pal.Com Inc. filed its annual 10-K, revealing a net loss of $6.2 million, an accumulated deficit exceeding $109 million, and significant going concern uncertainties, despite reduced operating expenses.

Texas Mineral Resources Corp. files an amended annual report to update corporate governance, executive compensation, and related party transaction disclosures for the fiscal year ended August 31, 2025.

Citius Pharmaceuticals, Inc. reports a net loss of $39.7 million for fiscal year 2025, with its subsidiary Citius Oncology launching LYMPHIR amidst ongoing funding needs and product development.

Citius Oncology launched its lead product LYMPHIR in December 2025, but faces substantial doubt about its ability to continue as a going concern due to recurring losses and a need for significant additional funding.

Barnwell Industries reported a significant net loss for fiscal year 2025, driven by decreased oil and natural gas revenues, asset sales, and substantial legal expenses, despite a recent capital raise.